Current HIV/AIDS Reports

Papers
(The TQCC of Current HIV/AIDS Reports is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Spiraling Risk: Visualizing the multilevel factors that socially pattern HIV risk among gay, bisexual & other men who have sex with men using Complex Systems Theory73
Adventures in COVID-19 Policy Modeling: Education Edition62
Syndemic Theory and Its Use in Developing Health Interventions and Programming: A Scoping Review46
Challenges and Opportunities in Big Data Science to Address Health Inequities and Focus the HIV Response44
Feasibility and Impact of Community Pharmacy and Novel Pick-up Points for Antiretroviral Therapy Pre-exposure Prophylaxis Initiation and Continuation in Low and Middle-income Countries44
Examining the Use of HIV Self-Testing to Support PrEP Delivery: a Systematic Literature Review34
Validity of Digital Assessments in Screening for HIV-Related Cognitive Impairment: a Review33
Long-Acting Injectable Cabotegravir for HIV Prevention: What Do We Know and Need to Know about the Risks and Consequences of Cabotegravir Resistance?33
Ethical Perspectives in Using Technology-Enabled Research for Key HIV Populations in Rights-Constrained Settings32
Differentiated Service Delivery Models for Maintaining HIV Treatment and Prevention Services During Crisis and Disease Outbreaks: Lessons from the COVID-19 Pandemic29
Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames?28
Implementation Science of Integrating Pre-Exposure Prophylaxis in Pharmacist-Led Services in the United States27
Interventions to Improve Adolescent HIV Care Outcomes27
More than the Infinite Monkey Theorem: NHP Models in the Development of a Pediatric HIV Cure25
Current Status of HIV-Stigma Reduction Interventions: A Need to Address the Root Causes at Multiple Levels25
Consolidated Overview of Notifiable Adverse Events in the U.S. President’s Emergency Plan for AIDS Relief’s Voluntary Medical Male Circumcision Program Through 202025
COVID-19: Impact on the HIV and Tuberculosis Response, Service Delivery, and Research in South Africa24
Intestinal Microbiota and Aging in People with HIV—What We Know and What We Don’t24
Risk-Based Screening Tools to Optimise HIV Testing Services: a Systematic Review23
Risk Compensation in Voluntary Medical Male Circumcision Programs23
Update on Central Nervous System Effects of HIV in Adolescents and Young Adults22
Future of bNAbs in HIV Treatment21
Voluntary Medical Male Circumcision for HIV Prevention: a Global Overview21
PrEP Method Switching: Will it Yield Greater Coverage of HIV Protection? Applying Lessons Learned from Family Planning to Guide Future Research in the Context of PrEP Choice21
Transition to Adult Care for Young People Living with HIV21
Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program21
VMMC Programmatic Successes and Challenges: Western Kenya Case Study19
Sex Differences in Metabolic Disorders of Aging and Obesity in People with HIV17
Medicinal Plant and Traditional Knowledge-guided Strategies to Combat HIV Persistence17
A Review of Serious Gaming as an Intervention for HIV Prevention16
Awareness of Heightened Sexual and Behavioral Vulnerability as a Trigger for PrEP Resumption Among Adolescent Girls and Young Women in East and Southern Africa16
Ingestible Electronic Sensors for Monitoring Real-time Adherence to HIV Pre-exposure Prophylaxis and Antiretroviral Therapy15
Intervention Approaches to Address Intimate Partner Violence and HIV: a Scoping Review of Recent Research15
Update on Vaccination Recommendations for Adults with HIV15
Long-Acting Injectable Antiretroviral Therapy for Treatment of Human Immunodeficiency Virus: A Review15
Getting HIV Pre-exposure Prophylaxis (PrEP) into Private Pharmacies: Global Delivery Models and Research Directions15
HIV Prevention Tools Across the Pregnancy Continuum: What Works, What Does Not, and What Can We Do Differently?15
HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups15
Genomic Exploration of the Brain in People Infected with HIV—Recent Progress and the Road Ahead14
Fatty Liver Disease: Enter the Metabolic Era14
Mpox and HIV: a Narrative Review13
Soluble Biomarkers of Cognition and Depression in Adults with HIV Infection in the Combination Therapy Era13
Long-Acting Injectable Antiretroviral Drugs for Pregnant and Breastfeeding Women: Current Advances, Challenges, and Future Directions13
PEPFAR’s Role in Protecting and Leveraging HIV Services in the COVID-19 Response in Africa13
Challenges of HIV Management in an Aging Population12
Advances in HIV Research Using Mass Cytometry12
Correction to: Peer-Led Adjunctive Interventions for Increasing the Reach of HIV Prevention and Care Interventions to Latino/x/e Men Who Have Sex with Men: a Scoping Review12
The Impact of Cannabis Use on Cognition in People with HIV: Evidence of Function-Dependent Effects and Mechanisms from Clinical and Preclinical Studies12
0.21159219741821